Giant Cell Tumor of Bone

The role of enhanced fluorodeoxyglucose F 18 uptake of giant cell tumor of bone (GCTB) should be mentioned in an overview such as that reported by van der Heijden et al., with regard not only to the response to denosumab treatment for unresectable GCTB but also to the clinical implications for the d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2014-11, Vol.19 (11), p.1207-1207
Hauptverfasser:	Cavanna, Luigi, Biasini, Claudia, Monfredo, Michela, Maniscalco, Pietro, Mori, Monica
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized - therapeutic use Bone Neoplasms Diphosphonates - therapeutic use Female Giant Cell Tumor of Bone Humans Letters to the Editor Male RANK Ligand - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The role of enhanced fluorodeoxyglucose F 18 uptake of giant cell tumor of bone (GCTB) should be mentioned in an overview such as that reported by van der Heijden et al., with regard not only to the response to denosumab treatment for unresectable GCTB but also to the clinical implications for the diagnosis of this disease.
ISSN:	1083-7159 1549-490X
DOI:	10.1634/theoncologist.2014-0267